New hope for rectal cancer patients: Triple-Threat treatment trial
NCT ID NCT07281768
Summary
This study tests whether adding newer immunotherapy drugs to standard chemotherapy before surgery works better for rectal cancer that hasn't spread. Researchers will compare three different drug combinations in 66 patients to see which helps shrink tumors most effectively with acceptable side effects. The goal is to improve outcomes so patients might avoid more extensive surgery or have better long-term results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.